Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9APB3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 327 | 331 | PF00656 | 0.581 |
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.590 |
CLV_NRD_NRD_1 | 236 | 238 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.630 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.575 |
CLV_PCSK_FUR_1 | 234 | 238 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.625 |
CLV_PCSK_KEX2_1 | 236 | 238 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.575 |
CLV_PCSK_PC1ET2_1 | 53 | 55 | PF00082 | 0.519 |
CLV_PCSK_SKI1_1 | 304 | 308 | PF00082 | 0.570 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.591 |
DOC_CYCLIN_yCln2_LP_2 | 42 | 48 | PF00134 | 0.617 |
DOC_MAPK_MEF2A_6 | 276 | 284 | PF00069 | 0.486 |
DOC_PP4_MxPP_1 | 88 | 91 | PF00568 | 0.470 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.719 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.658 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.621 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.608 |
LIG_14-3-3_CanoR_1 | 104 | 112 | PF00244 | 0.349 |
LIG_14-3-3_CanoR_1 | 63 | 68 | PF00244 | 0.537 |
LIG_APCC_ABBAyCdc20_2 | 65 | 71 | PF00400 | 0.448 |
LIG_BIR_III_2 | 146 | 150 | PF00653 | 0.521 |
LIG_BRCT_BRCA1_1 | 312 | 316 | PF00533 | 0.564 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.434 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.739 |
LIG_LIR_Gen_1 | 131 | 139 | PF02991 | 0.522 |
LIG_LIR_Gen_1 | 190 | 198 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 202 | 208 | PF02991 | 0.391 |
LIG_LIR_Gen_1 | 313 | 321 | PF02991 | 0.668 |
LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 190 | 194 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 197 | 201 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 202 | 206 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 313 | 319 | PF02991 | 0.665 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 71 | 77 | PF02991 | 0.454 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.495 |
LIG_SH2_STAT3 | 229 | 232 | PF00017 | 0.538 |
LIG_SH2_STAT5 | 191 | 194 | PF00017 | 0.450 |
LIG_SH3_3 | 154 | 160 | PF00018 | 0.764 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.444 |
LIG_TRAF2_1 | 253 | 256 | PF00917 | 0.606 |
LIG_TRAF2_1 | 324 | 327 | PF00917 | 0.563 |
LIG_TRAF2_1 | 335 | 338 | PF00917 | 0.443 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.580 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.727 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.721 |
MOD_CK2_1 | 321 | 327 | PF00069 | 0.571 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.608 |
MOD_GlcNHglycan | 16 | 20 | PF01048 | 0.643 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.681 |
MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.473 |
MOD_GlcNHglycan | 295 | 300 | PF01048 | 0.704 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.446 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.596 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.693 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.648 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.704 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.443 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.624 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.472 |
MOD_PIKK_1 | 228 | 234 | PF00454 | 0.538 |
MOD_PKA_1 | 236 | 242 | PF00069 | 0.542 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.656 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.452 |
MOD_PKB_1 | 140 | 148 | PF00069 | 0.564 |
MOD_PKB_1 | 234 | 242 | PF00069 | 0.540 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.505 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.424 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.345 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.621 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.610 |
MOD_SUMO_for_1 | 289 | 292 | PF00179 | 0.567 |
MOD_SUMO_rev_2 | 296 | 306 | PF00179 | 0.748 |
TRG_AP2beta_CARGO_1 | 131 | 141 | PF09066 | 0.589 |
TRG_DiLeu_BaEn_1 | 265 | 270 | PF01217 | 0.517 |
TRG_DiLeu_BaLyEn_6 | 190 | 195 | PF01217 | 0.452 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.454 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 233 | 236 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 257 | 259 | PF00400 | 0.533 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 98 | 101 | PF00400 | 0.495 |
TRG_NLS_MonoExtC_3 | 51 | 56 | PF00514 | 0.523 |
TRG_Pf-PMV_PEXEL_1 | 193 | 197 | PF00026 | 0.445 |
TRG_Pf-PMV_PEXEL_1 | 242 | 246 | PF00026 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 257 | 262 | PF00026 | 0.544 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2K8 | Leptomonas seymouri | 57% | 90% |
A0A0S4IK25 | Bodo saltans | 31% | 83% |
A0A1X0NN31 | Trypanosomatidae | 42% | 100% |
A0A3S7WSI8 | Leishmania donovani | 90% | 100% |
A4H777 | Leishmania braziliensis | 75% | 99% |
A4HVL7 | Leishmania infantum | 90% | 100% |
D0A6N8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
Q4QG65 | Leishmania major | 89% | 100% |
V5BK51 | Trypanosoma cruzi | 42% | 100% |